Cargando…
Time to market access in Italia: durata del processo di P&R per i farmaci per le malattie rare
OBJECTIVE: This paper aims to investigate the duration of the pricing & reimbursement (P&R) procedures submitted in Italy by pharmaceutical marketing authorization holders (MAH) for drugs indicated for rare diseases. METHODS: All the data used in this analysis were publicly available on diff...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AboutScience
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628501/ https://www.ncbi.nlm.nih.gov/pubmed/37942299 http://dx.doi.org/10.33393/grhta.2023.2610 |